Covered recipient · General Payments record
RONALD LEE BARNES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$328.02
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.90 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $47.16 | 2 |
| Lilly USA, LLC | $38.33 | 2 |
| Amgen Inc. | $34.85 | 2 |
| Acerta Pharma LLC | $32.58 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.44 | 1 |
| PFIZER INC. | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103281673 | CMS |
| ABBVIE INC. | $30.95 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103281675 | CMS |
| Amgen Inc. | $18.64 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440458 | CMS |
| Amgen Inc. | $16.21 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115440462 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.66 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104700849 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.92 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105660648 | CMS |
| Lilly USA, LLC | $19.41 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135358490 | CMS |
| Lilly USA, LLC | $18.92 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135390765 | CMS |
| PFIZER INC. | $17.54 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131145859 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144611416 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.